Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome against Experimental Catheter-associated Biofilm Infection due to Staphylococcus aureus
Biofilm formations play an important role in Staphylococcus aureus pathogenesis and contribute to antibiotic treatment failures in biofilm-associated infections. The aim of this study was to evaluate the pharmacokinetic/pharmacodynamic (PK/PD) profiles of cefquinome against an experimental catheter-...
| 出版年: | Frontiers in Microbiology |
|---|---|
| 主要な著者: | Yu-Feng eZhou, Wei eShi, Yang eYu, Meng-Ting eTao, Yan Q. eXiong, Jian eSun, Ya-Hong eLiu |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Frontiers Media S.A.
2016-01-01
|
| 主題: | |
| オンライン・アクセス: | http://journal.frontiersin.org/Journal/10.3389/fmicb.2015.01513/full |
類似資料
Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
著者:: Ijaz eAhmad, 等
出版事項: (2015-06-01)
著者:: Ijaz eAhmad, 等
出版事項: (2015-06-01)
Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an in vitro Model
著者:: Yafei eLi, 等
出版事項: (2016-04-01)
著者:: Yafei eLi, 等
出版事項: (2016-04-01)
Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
著者:: Longfei Zhang, 等
出版事項: (2020-08-01)
著者:: Longfei Zhang, 等
出版事項: (2020-08-01)
Ex Vivo Pharmacokinetic/Pharmacodynamic Integration Model of Cefquinome Against <i>Escherichia coli</i> in Foals
著者:: Tiantian Gao, 等
出版事項: (2025-03-01)
著者:: Tiantian Gao, 等
出版事項: (2025-03-01)
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals
著者:: Dong-Ha Lee, 等
出版事項: (2020-10-01)
著者:: Dong-Ha Lee, 等
出版事項: (2020-10-01)
PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model
著者:: Yanzhe Wei, 等
出版事項: (2023-10-01)
著者:: Yanzhe Wei, 等
出版事項: (2023-10-01)
Effect of Meloxicam on the Pharmacokinetics of Cefquinome in Endotoxemic Sheep
著者:: Muhittin Uslu, 等
出版事項: (2025-09-01)
著者:: Muhittin Uslu, 等
出版事項: (2025-09-01)
Lung microdialysis and in vivo PK/PD integration of cefquinome against Actinobacillus pleuropneumoniae in a porcine experimental lung infection model
著者:: Yuqin Chen, 等
出版事項: (2024-03-01)
著者:: Yuqin Chen, 等
出版事項: (2024-03-01)
Susceptibility breakpoint for cefquinome against Escherichia coli and Staphylococcus aureus from pigs
著者:: Hui-lin ZHANG, 等
出版事項: (2021-07-01)
著者:: Hui-lin ZHANG, 等
出版事項: (2021-07-01)
Microdialysis Determination of Cefquinome Pharmacokinetics in Murine Thigh From Healthy, Neutropenic, and Actinobacillus pleuropneumoniae-Infected Mice
著者:: Longfei Zhang, 等
出版事項: (2019-03-01)
著者:: Longfei Zhang, 等
出版事項: (2019-03-01)
Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
著者:: Kun Mi, 等
出版事項: (2021-01-01)
著者:: Kun Mi, 等
出版事項: (2021-01-01)
Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)
著者:: Dong-Hao Zhao, 等
出版事項: (2017-07-01)
著者:: Dong-Hao Zhao, 等
出版事項: (2017-07-01)
Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus
著者:: Yong-hui Zhou, 等
出版事項: (2018-04-01)
著者:: Yong-hui Zhou, 等
出版事項: (2018-04-01)
Pharmacokinetics and Residues of Cefquinome in Milk of Lactating Chinese Dairy Cows After Intramammary Administration
著者:: Ya-fei LI, 等
出版事項: (2014-12-01)
著者:: Ya-fei LI, 等
出版事項: (2014-12-01)
Environmental fate of cefquinome: Adsorption and degradation
著者:: Jicheng Qiu, 等
出版事項: (2022-10-01)
著者:: Jicheng Qiu, 等
出版事項: (2022-10-01)
Adaptive Resistance of <i>Staphylococcus aureus</i> to Cefquinome Sulfate in an In Vitro Pharmacokinetic Model with Transcriptomic Insights
著者:: Yue Hu, 等
出版事項: (2025-02-01)
著者:: Yue Hu, 等
出版事項: (2025-02-01)
Disposition of Cefquinome in Turkeys (<i>Meleagris gallopavo</i>) Following Intravenous and Intramuscular Administration
著者:: Mohamed Elbadawy, 等
出版事項: (2021-10-01)
著者:: Mohamed Elbadawy, 等
出版事項: (2021-10-01)
Pharmacokinetics and relative bioavailability study of two cefquinome sulfate intramammary infusions in cow milk
著者:: Shuang Li, 等
出版事項: (2024-03-01)
著者:: Shuang Li, 等
出版事項: (2024-03-01)
Migration of Cefquinome Antibiotic Residues from Milk to Dairy Products
著者:: Melissa Di Rocco, 等
出版事項: (2021-11-01)
著者:: Melissa Di Rocco, 等
出版事項: (2021-11-01)
In vivo pharmacokinetic and pharmacodynamic profiles of orbifloxacin against Staphylococcus aureus in a neutropenic murine thigh infection model
著者:: Long-Gen Zhong, 等
出版事項: (2025-08-01)
著者:: Long-Gen Zhong, 等
出版事項: (2025-08-01)
Elimination of Cefquinome Sulfate Residue in Cow’s Milk after Intrauterine Infusion
著者:: Chunshuang Liu, 等
出版事項: (2023-03-01)
著者:: Chunshuang Liu, 等
出版事項: (2023-03-01)
Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting
著者:: Shaoqi Qu, 等
出版事項: (2017-01-01)
著者:: Shaoqi Qu, 等
出版事項: (2017-01-01)
Determination of Susceptibility Breakpoint for Cefquinome against <i>Streptococcus suis</i> in Pigs
著者:: Kun Mi, 等
出版事項: (2021-08-01)
著者:: Kun Mi, 等
出版事項: (2021-08-01)
Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Methods for the Quantification of Cefquinome, Ceftiofur, and Desfuroylceftiofuracetamide in Porcine Feces with Emphasis on Analyte Stability
著者:: Sofie Rutjens, 等
出版事項: (2021-07-01)
著者:: Sofie Rutjens, 等
出版事項: (2021-07-01)
Pharmacokinetic and pharmacodynamic integration and modeling of enrofloxacin in swine for Escherichia coli
著者:: Jianyi eWang, 等
出版事項: (2016-02-01)
著者:: Jianyi eWang, 等
出版事項: (2016-02-01)
Pharmacokinetic-Pharmacodynamic modeling of enrofloxacin against Escherichia coli in broilers
著者:: Sang eKana, 等
出版事項: (2016-01-01)
著者:: Sang eKana, 等
出版事項: (2016-01-01)
In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
著者:: Yang Yu, 等
出版事項: (2016-01-01)
著者:: Yang Yu, 等
出版事項: (2016-01-01)
Gastric Acid-Protective and Intestinal Targeted Nanogels Enable Anti-Bacterial Activity of Cefquinome
著者:: Xianqiang Li, 等
出版事項: (2025-06-01)
著者:: Xianqiang Li, 等
出版事項: (2025-06-01)
In vivo pharmacokinetic and pharmacodynamic study and cutoff of florfenicol against Riemerella anatipestifer in ducks
著者:: Hui-Lin Zhang, 等
出版事項: (2025-01-01)
著者:: Hui-Lin Zhang, 等
出版事項: (2025-01-01)
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
著者:: Xin-Yi Wei, 等
出版事項: (2024-04-01)
著者:: Xin-Yi Wei, 等
出版事項: (2024-04-01)
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant <i>Staphylococcus aureus</i>
著者:: Katharina Rox, 等
出版事項: (2022-12-01)
著者:: Katharina Rox, 等
出版事項: (2022-12-01)
Importance of Pharmacokinetic/Pharmacodynamic Concept in Antibiotic Therapy
著者:: Tuğba Gümüștaș, 等
出版事項: (2018-04-01)
著者:: Tuğba Gümüștaș, 等
出版事項: (2018-04-01)
A methodological review on the pharmacokinetic/pharmacodynamic integration of antibacterial drugs
著者:: Hongjuan WANG, 等
出版事項: (2022-02-01)
著者:: Hongjuan WANG, 等
出版事項: (2022-02-01)
Pharmacokinetics/pharmacodynamics of antibiotics with different protein binding rates in hemodialysis
著者:: SHEN Yue, 等
出版事項: (2025-06-01)
著者:: SHEN Yue, 等
出版事項: (2025-06-01)
Pharmacokinetic–Pharmacodynamic Modeling of Midazolam in Pediatric Surgery
著者:: Carmen Flores-Pérez, 等
出版事項: (2023-11-01)
著者:: Carmen Flores-Pérez, 等
出版事項: (2023-11-01)
Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application
著者:: Jean Claude Alvarez, 等
出版事項: (2022-02-01)
著者:: Jean Claude Alvarez, 等
出版事項: (2022-02-01)
Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against <i>Staphylococcus pseudintermedius</i> in Dogs
著者:: Ji-Soo Jeong, 等
出版事項: (2024-12-01)
著者:: Ji-Soo Jeong, 等
出版事項: (2024-12-01)
Pharmacokinetic and Pharmacodynamic Modeling of Enrofloxacin and Its Metabolite Ciprofloxacin in Pregnant Goats
著者:: Luis Adrian Ambros, 等
出版事項: (2025-06-01)
著者:: Luis Adrian Ambros, 等
出版事項: (2025-06-01)
Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia
著者:: Eliel Nham, 等
出版事項: (2022-08-01)
著者:: Eliel Nham, 等
出版事項: (2022-08-01)
Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
著者:: Minsoo Kim, 等
出版事項: (2019-03-01)
著者:: Minsoo Kim, 等
出版事項: (2019-03-01)
類似資料
-
Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
著者:: Ijaz eAhmad, 等
出版事項: (2015-06-01) -
Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an in vitro Model
著者:: Yafei eLi, 等
出版事項: (2016-04-01) -
Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
著者:: Longfei Zhang, 等
出版事項: (2020-08-01) -
Ex Vivo Pharmacokinetic/Pharmacodynamic Integration Model of Cefquinome Against <i>Escherichia coli</i> in Foals
著者:: Tiantian Gao, 等
出版事項: (2025-03-01) -
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals
著者:: Dong-Ha Lee, 等
出版事項: (2020-10-01)
